Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | UGT2B7 | P16662 | 1/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.47 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.44 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.44 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16684715 | 1.00 | UGT2B7 (0.59) | UGT2B7CYP1A2MEN1KMT2ACYP2D6 | |
| SCHEMBL2491242 | 0.94 | UGT2B7 (0.52) | UGT2B7CYP1A2MEN1KMT2ACYP2D6 | |
| SCHEMBL9167387 | 0.91 | ALDH1A1 (0.53) | UGT2B7TSHRUSP2ALDH1A1GAA | |
| SCHEMBL3725681 | 0.87 | ALDH1A1 (0.50) | UGT2B7TSHRUSP2ALDH1A1GAA | |
| SCHEMBL3727201 | 0.87 | ALDH1A1 (0.50) | UGT2B7TSHRUSP2ALDH1A1GAA | |
| SCHEMBL19164262 | 0.86 | UGT2B7 (0.58) | UGT2B7CYP1A2MEN1KMT2ACYP2D6 | |
| SCHEMBL11051116 | 0.84 | UGT2B7 (0.55) | UGT2B7CYP1A2MEN1KMT2ACYP2D6 | |
| SCHEMBL11998991 | 0.83 | SLC7A5 (0.47) | UGT2B7CYP1A2MEN1KMT2ACYP2D6 | |
| SCHEMBL11999024 | 0.83 | MTNR1A (0.43) | UGT2B7CYP2D6AOC3HDAC4HDAC2 | |
| SCHEMBL12299095 | 0.82 | UGT2B7 (0.44) | UGT2B7CYP1A2MEN1KMT2ACYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102260134-A | Preparation method of 2-sec-butylnaphthalene | — | 2011-11-30 | — | — | CN | claimed |
| JP-52106852-A | — | — | None | — | — | JP | disclosed |
| CN-114534787-B | Gas-phase dehydrogenation catalyst and method for isopentenol | 万华化学集团股份有限公司 | 2023-12-19 | — | — | CN | disclosed |
| US-20230375928-A1 | Sulfonium-Salt-Type Polymerizable Monomer, Polymer Photoacid Generator, Base Rein, Resist Composition, And Patterning Process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-11-23 | — | — | US | disclosed |
| EP-3063154-B1 | CROSS-COUPLING OF UNACTIVATED SECONDARY BORONIC ACIDS | UNIV ILLINOIS (US) | 2023-08-30 | — | — | EP | disclosed |
| CN-111013609-B | Metal oxide super acidic catalyst, preparation method and application thereof | 中国石油化工股份有限公司 | 2023-04-07 | — | — | CN | disclosed |
| CN-111013609-A | Metal oxide super acidic catalyst, preparation method and application thereof | 中国石油化工股份有限公司 | 2020-04-17 | — | — | CN | disclosed |
| US-10570153-B2 | Benzodiazepine derivatives as RSV inhibitors | ENANTA PHARMACEUTICALS, INC. (US) | 2020-02-25 | — | — | US | disclosed |
| US-20190033716-A1 | SULFONIUM SALT, POLYMER, RESIST COMPOSITION, AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2019-01-31 | — | — | US | disclosed |
| US-10072028-B2 | Cross-coupling of unactivated secondary boronic acids | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2018-09-11 | — | — | US | disclosed |
| EP-0484319-A1 | A process of producing isopropylnaphthols | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1992-05-06 | — | — | EP | disclosed |
| EP-0440250-A2 | Method of preparing alkylnaphthalene compounds | NIPPON SHOKUBAI CO., LTD. (JP) | 1991-08-07 | — | — | EP | disclosed |
| US-4906790-A | Method of oxidizing secondary alkyl substituted naphtalenes and a process of producing isopropylnaphthols | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1990-03-06 | — | — | US | disclosed |
| CN-1003786-B | Acylation of naphthalene | 赛拉尼斯公司 | 1989-04-05 | — | — | CN | disclosed |
| EP-0308133-A1 | A method of oxidising secondary alkyl substituted naphthalenes | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1989-03-22 | — | — | EP | disclosed |
| US-4783557-A | Processes for preparing hydroxynaphthalenes | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1988-11-08 | — | — | US | disclosed |
| CN-86101420-A | The acidylate of naphthalene | — | 1986-11-12 | — | — | CN | disclosed |
| EP-0196805-A1 | Acylation of naphthalenes | CELANESE CORPORATION (US) | 1986-10-08 | — | — | EP | disclosed |
| US-4593125-A | In anhydrous hydrogen fluoride | CELANESE CORPORATION (US) | 1986-06-03 | — | — | US | disclosed |
| JP-S52106852-A | BETA-SECONDARY-BUTYLNAPHTHALENES | AGENCY OF IND SCIENCE & TECHNOL | 1977-09-07 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10570153-B2 | Benzodiazepine derivatives as RSV inhibitors | GABRA5, GABRA1, GABBR2 | UGT2B7 139/4885CYP1A2 58/4885MEN1 3463/4885 |
| US-20190033716-A1 | SULFONIUM SALT, POLYMER, RESIST COMPOSITION, AND PATTERNING PROCESS | SMC4, SMCHD1, SMC3 | UGT2B7 3209/4885CYP1A2 4863/4885MEN1 3961/4885 |
| US-10072028-B2 | Cross-coupling of unactivated secondary boronic acids | BOLA2; BOLA2B, BLVRB, CD79B | UGT2B7 226/4885CYP1A2 1283/4885MEN1 449/4885 |
| US-20230375928-A1 | Sulfonium-Salt-Type Polymerizable Monomer, Polymer Photoacid Generator, Base Rein, Resist Composition, And Patterning Process | NAF1, RALA, RSU1 | UGT2B7 4327/4885CYP1A2 3948/4885MEN1 3472/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.